The N-terminal pro-brain natriuretic peptide (NT-proBNP) as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients

被引：0
|
作者：
Podlecka-Pietowska, A. [1 ]
Kochanowski, J. [2 ]
Zakrzewska-Pniewska, B. [1 ]
Nojszewska, M. [1 ]
Kaminska, A. [1 ]
Opolski, G. [2 ]
Kwiecinski, H. [1 ]
机构：
[1] Med Univ, Dept Neurol, Warsaw, Poland
[2] Med Univ, Dept Cardiol, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [21] Is the aminoterminal pro-brain natriuretic peptide (NT-proBNP) a marker for diabetic polyneuropathy?
    Jurado, J.
    Pou, Jose M.
    Escudero, Elena
    Ybarra, J.
    DIABETES, 2007, 56 : A206 - A206
  • [22] Influence of hemodialysis membranes on the elimination of N terminal pro-brain natriuretic peptide (NT-proBNP)
    Giannikouris, Ioannis
    Alivanis, Polichronis
    Paliuras, Christos
    Kaligas, Georgios
    Arvanitis, Antonios
    Volanaki, Maria
    Bornivelli, Christina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 25 - 25
  • [23] Plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients after myocardial infarction:: a biochemical marker of cardio-renal function
    Luchner, A
    Hengstenberg, C
    Löwel, H
    Trawinski, J
    Baumann, M
    Holmer, S
    Riegger, GA
    Schunkert, H
    EUROPEAN HEART JOURNAL, 2001, 22 : 304 - 304
  • [24] N-terminal pro-brain natriuretic peptide (NT-proBNP) as screening test for early stage heart failure.
    Triepels, RH
    Busscher, S
    van der Burgh, PH
    Vermes, I
    CLINICAL CHEMISTRY, 2003, 49 (06) : A37 - A38
  • [25] Reduction of unnecessary N-terminal pro-brain natriuretic peptide (NT-proBNP) tests: A further lesson in demand management
    Livingston, Mark
    Kalansooriya, Anura
    Hartland, Andrew
    Fryer, Anthony A.
    Gupta, Jayant
    Heald, Adrian H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2018, 72 (04)
  • [26] N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study
    Bower, Julie K.
    Lazo, Mariana
    Matsushita, Kunihiro
    Rubin, Jonathan
    Hoogeveen, Ron C.
    Ballantyne, Christie M.
    Selvin, Elizabeth
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (10) : 1262 - 1266
  • [27] Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes
    Verges, B.
    Zeller, M.
    Beer, J. -C.
    Cottin, Y.
    DIABETES & METABOLISM, 2008, 34 : S10 - S15
  • [28] Evaluation of Plasma N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Concentrations in Dogs with Mitral Valve Insufficiency
    Takemura, Naoyuki
    Toda, Noriko
    Miyagawa, Yuichi
    Asano, Kazuyuki
    Tejima, Kenji
    Kanno, Nobuyuki
    Arisawa, Kohji
    Kurita, Tohru
    Nunokawa, Kohji
    Hirakawa, Atsushi
    Tanaka, Shigeo
    Hirose, Hisashi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2009, 71 (07): : 925 - 929
  • [29] Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: Comparison with brain natriuretic peptide (BNP)
    Chenevier-Gobeaux, C
    Claessens, YE
    Voyer, S
    Desmoulins, D
    Ekindjian, OGJC
    CLINICA CHIMICA ACTA, 2005, 361 (1-2) : 167 - 175
  • [30] ANTIRHEUMATIC THERAPY IS NOT ASSOCIATED WITH CHANGES IN CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Thao Nguyen
    Deyab, Gia
    Fagerland, Morten
    Agewall, Stefan
    Eilertsen, Gro
    Feinberg, Mark
    Mikkelsen, Knut
    Forre, Oystein
    Hollan, Ivana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1628 - 1629
12345